DexCom
DXCM
DXCM
890 hedge funds and large institutions have $24.4B invested in DexCom in 2025 Q3 according to their latest regulatory filings, with 110 funds opening new positions, 326 increasing their positions, 338 reducing their positions, and 128 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
14% less first-time investments, than exits
New positions opened: 110 | Existing positions closed: 128
23% less capital invested
Capital invested by funds: $31.7B → $24.4B (-$7.3B)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
890
Holding in Top 10
6
Calls
$480M
Puts
$539M
Top Buyers
| 1 | +$364M | |
| 2 | +$214M | |
| 3 | +$164M | |
| 4 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$154M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$150M |
Top Sellers
| 1 | -$337M | |
| 2 | -$220M | |
| 3 | -$204M | |
| 4 |
Axa
Paris,
France
|
-$189M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$142M |
